Healthcare - Biotechnology - NASDAQ - US
$ 1.61
0.625 %
$ 83.3 M
Market Cap
-1.61
P/E
BALANCE SHEET
252 M
ASSETS
26.5 M
LIABILITIES
226 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
PMV Pharmaceuticals, Inc.
| Current Assets | 207 M |
| Cash & Short-Term Investments | 203 M |
| Receivables | 0 |
| Other Current Assets | 4.35 M |
| Non-Current Assets | 44.7 M |
| Long-Term Investments | 25.5 M |
| PP&E | 19 M |
| Other Non-Current Assets | 190 K |
| Current Liabilities | 14 M |
| Accounts Payable | 3.24 M |
| Short-Term Debt | 1.7 M |
| Other Current Liabilities | 9.09 M |
| Non-Current Liabilities | 12.4 M |
| Long-Term Debt | 12.4 M |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 37.7 | 108.3 | 172.5 | 361.4 | 73.3 | 30.3 |
| Short Term Investments | 165.4 | 132.8 | 124.7 | 0 | 28.2 | 31.6 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 4.4 | 6.0 | 4.1 | 6.7 | 0.6 | 0.3 |
| Total Current Assets | 207.4 | 247.0 | 301.3 | 364.8 | 102.1 | 62.2 |
| PP&E | 19.0 | 20.5 | 13.2 | 0.6 | 0.7 | 1.0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 25.5 | 2.5 | 16.9 | 0 | 0 | 0 |
| Other Long Term Assets | 0.2 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 252.2 | 270.3 | 331.6 | 365.5 | 103.0 | 63.5 |
| LIABILITIES | ||||||
| Accounts Payable | 3.2 | 3.0 | 3.2 | 1.6 | 2.8 | 1.0 |
| Short Term Debt | 1.7 | 1.1 | 0.8 | 0 | 0 | 0 |
| Other Current Liabilities | 9.1 | 6.8 | 8.2 | 4.8 | 1.7 | 1.3 |
| Total Current Liabilities | 14.0 | 10.8 | 12.2 | 6.4 | 4.5 | 2.3 |
| Long Term Debt | 12.4 | 13.4 | 10.8 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 0 | 169.0 | 107.3 |
| Total Liabilities | 26.5 | 24.3 | 23.0 | 6.4 | 173.5 | 109.6 |
| EQUITY | ||||||
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | (310.0) | (241.0) | (167.7) | (109.9) | (75.4) | (50.1) |
| Other Accumulative Comprehensive Income/Loss | 0.2 | (0.4) | 78 K | 0 | 3 K | 13 K |
| Total Equity | 225.7 | 246.0 | 308.6 | 359.1 | (70.5) | (46.1) |
| Total Liabilities and Equity | 252.2 | 270.3 | 331.6 | 365.5 | 103.0 | 63.5 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 48.0 | 45.6 | 45.1 | 44.8 | 43.0 | 31.2 |